• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽下调人类风湿性滑膜成纤维细胞中Toll样受体4(TLR4)的表达以及TLR4介导的趋化因子生成。

VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts.

作者信息

Gutiérrez-Cañas I, Juarranz Y, Santiago B, Arranz A, Martinez C, Galindo M, Payá M, Gomariz R P, Pablos J L

机构信息

Servicio de Reumatología, Hospital 12 de Octubre, Avda. de Córdoba s/n 28041, Madrid, Spain.

出版信息

Rheumatology (Oxford). 2006 May;45(5):527-32. doi: 10.1093/rheumatology/kei219. Epub 2005 Nov 30.

DOI:10.1093/rheumatology/kei219
PMID:16319097
Abstract

OBJECTIVES

Vasoactive intestinal peptide (VIP) has demonstrated therapeutic effects in arthritis by inhibiting both innate and acquired immune responses. We investigated the potential effects of VIP in the regulation of Toll-like receptor (TLR) expression and function in synovial fibroblasts from patients with rheumatoid arthritis (RA) and osteoarthritis (OA).

METHODS

Cultured fibroblast-like synoviocytes (FLS) were obtained from patients with RA and OA. The effects of VIP on basal or TNF-alpha or lipopolysaccharide (LPS)-induced TLR2, TLR4 and MyD88 expression and its effects on TLR4-mediated CCL2 and CXCL8 chemokine production were studied by reverse transcription-polymerase chain reaction, western blotting and enzyme-linked immunosorbent assay.

RESULTS

TLR2, TLR4 and MyD88 mRNA expression was increased in RA FLS compared with OA FLS. The largest increase was observed for TLR4 and there was also overexpression at the protein level in RA FLS. TLR4 and MyD88 mRNA and proteins were induced by LPS and TNF-alpha in RA FLS. VIP down-regulated the induced but not the constitutive expression of TLR4 and MyD88 in RA FLS. VIP treatment decreased CCL2 and CXCL8 chemokine production in response to TLR4 activation with LPS in RA FLS.

CONCLUSIONS

We demonstrate that VIP down-regulates LPS and TNF-alpha activation of TLR4 expression and the TLR4 functional response in terms of proinflammatory chemokine production. These studies suggest that the pleiotropic anti-inflammatory actions of VIP involve inhibitory effects on TLR4 expression and signalling.

摘要

目的

血管活性肠肽(VIP)已通过抑制先天性和获得性免疫反应在关节炎中显示出治疗作用。我们研究了VIP对类风湿性关节炎(RA)和骨关节炎(OA)患者滑膜成纤维细胞中Toll样受体(TLR)表达和功能的潜在影响。

方法

从RA和OA患者中获取培养的成纤维样滑膜细胞(FLS)。通过逆转录-聚合酶链反应、蛋白质印迹法和酶联免疫吸附测定法研究VIP对基础或肿瘤坏死因子-α(TNF-α)或脂多糖(LPS)诱导的TLR2、TLR4和髓样分化因子88(MyD88)表达的影响及其对TLR4介导的趋化因子CCL2和CXCL8产生的影响。

结果

与OA FLS相比,RA FLS中TLR2、TLR4和MyD88 mRNA表达增加。TLR4的增加最为明显,并且在RA FLS的蛋白质水平上也存在过表达。LPS和TNF-α在RA FLS中诱导TLR4和MyD88 mRNA及蛋白质表达。VIP下调RA FLS中TLR4和MyD88的诱导表达而非组成型表达。VIP处理降低了RA FLS中LPS激活TLR4后CCL2和CXCL8趋化因子的产生。

结论

我们证明,就促炎趋化因子的产生而言,VIP下调LPS和TNF-α对TLR4表达的激活以及TLR4功能反应。这些研究表明,VIP的多效抗炎作用涉及对TLR4表达和信号传导的抑制作用。

相似文献

1
VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts.血管活性肠肽下调人类风湿性滑膜成纤维细胞中Toll样受体4(TLR4)的表达以及TLR4介导的趋化因子生成。
Rheumatology (Oxford). 2006 May;45(5):527-32. doi: 10.1093/rheumatology/kei219. Epub 2005 Nov 30.
2
Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells.血管活性肠肽调节骨关节炎和类风湿性关节炎滑膜细胞中促炎介质的合成。
Rheumatology (Oxford). 2004 Apr;43(4):416-22. doi: 10.1093/rheumatology/keh061. Epub 2003 Dec 1.
3
VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts.血管活性肠肽可逆转类风湿性关节炎滑膜成纤维细胞中Toll样受体4刺激的信号通路的表达谱。
Mol Immunol. 2008 Jun;45(11):3065-73. doi: 10.1016/j.molimm.2008.03.011. Epub 2008 May 2.
4
Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.血管活性肠肽及其功能性受体在人骨关节炎和类风湿性滑膜成纤维细胞中的差异表达。
Arthritis Rheum. 2008 Apr;58(4):1086-95. doi: 10.1002/art.23403.
5
Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts.Toll样受体2和4联合激活可协同上调人类风湿性滑膜成纤维细胞中的白细胞介素-15。
Immunol Lett. 2007 Mar 15;109(1):21-7. doi: 10.1016/j.imlet.2006.12.006. Epub 2007 Jan 17.
6
VIP decreases TLR4 expression induced by LPS and TNF-alpha treatment in human synovial fibroblasts.血管活性肠肽可降低脂多糖和肿瘤坏死因子-α处理诱导的人滑膜成纤维细胞中Toll样受体4的表达。
Ann N Y Acad Sci. 2006 Jul;1070:359-64. doi: 10.1196/annals.1317.045.
7
Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.白细胞介素(IL)-23 p19在类风湿关节炎患者的人成纤维样滑膜细胞中由IL-1β通过活性核因子-κB和AP-1依赖性途径诱导表达。
Rheumatology (Oxford). 2007 Aug;46(8):1266-73. doi: 10.1093/rheumatology/kem055. Epub 2007 Jun 14.
8
Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.转化生长因子β1(TGF-β1)通过核因子κB(NF-κB)介导的转录抑制作用下调类风湿性滑膜成纤维细胞中肿瘤坏死因子α(TNFα)诱导的调节激活正常T细胞表达和分泌的趋化因子(RANTES)的产生。
Immunol Lett. 2006 Jun 15;105(2):159-66. doi: 10.1016/j.imlet.2006.02.003. Epub 2006 Mar 3.
9
Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.人类风湿性滑膜成纤维细胞通过TLR - 2和TLR - 4激活来激活RANKL,从而促进破骨细胞生成活性。
Immunol Lett. 2007 May 15;110(1):54-64. doi: 10.1016/j.imlet.2007.03.004. Epub 2007 Apr 17.
10
Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis.类风湿关节炎和骨关节炎患者的成纤维样滑膜细胞中表达κ和δ阿片受体,但表达下调。
Arthritis Rheum. 2005 May;52(5):1402-10. doi: 10.1002/art.21141.

引用本文的文献

1
The impact of exogenous vasoactive intestinal polypeptide on inflammatory responses and mRNA expression of tight junction genes in lambs fed a high-grain diet.高谷物日粮对羔羊炎症反应及紧密连接基因 mRNA 表达的影响。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae309.
2
IL-22, a vital cytokine in autoimmune diseases.白细胞介素 22,一种自身免疫性疾病中的重要细胞因子。
Clin Exp Immunol. 2024 Nov 12;218(3):242-263. doi: 10.1093/cei/uxae035.
3
Vasoactive Intestinal Peptide (VIP) Protects Nile Tilapia () against Infection.血管活性肠肽(VIP)可保护尼罗罗非鱼()抵抗感染。
Int J Mol Sci. 2022 Nov 28;23(23):14895. doi: 10.3390/ijms232314895.
4
Xiaoyao-Qingluoyin Cure Adjuvant-Induced Arthritis by Easing LPS Response-Related Pathway-Mediated Immune Abnormality.逍遥清络饮通过缓解脂多糖反应相关途径介导的免疫异常来治疗佐剂性关节炎。
Evid Based Complement Alternat Med. 2022 Apr 25;2022:8536998. doi: 10.1155/2022/8536998. eCollection 2022.
5
RA Fibroblast-Like Synoviocytes Derived Extracellular Vesicles Promote Angiogenesis by miRNA-1972 Targeting p53/mTOR Signaling in Vascular Endotheliocyte.类风湿关节炎成纤维样滑膜细胞衍生的细胞外囊泡通过 miRNA-1972 靶向血管内皮细胞中的 p53/mTOR 信号通路促进血管生成。
Front Immunol. 2022 Mar 8;13:793855. doi: 10.3389/fimmu.2022.793855. eCollection 2022.
6
Effects of adenovirus-mediated knockdown of IRAK4 on synovitis in the osteoarthritis rabbit model.腺病毒介导的 IRAK4 基因沉默对骨关节炎兔模型滑膜炎症的影响。
Arthritis Res Ther. 2021 Dec 4;23(1):294. doi: 10.1186/s13075-021-02684-8.
7
Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4.可溶性 CD14 通过 Toll 样受体 4 诱导类风湿关节炎成纤维样滑膜细胞产生促炎细胞因子。
Cells. 2020 Jul 14;9(7):1689. doi: 10.3390/cells9071689.
8
A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.VIP 轴在炎症和自身免疫性疾病中的应用的临床方法。
Int J Mol Sci. 2019 Dec 20;21(1):65. doi: 10.3390/ijms21010065.
9
The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis.抗炎介质血管活性肠肽调节类风湿关节炎中 Th 亚群的分化和功能。
J Immunol Res. 2018 Aug 1;2018:6043710. doi: 10.1155/2018/6043710. eCollection 2018.
10
Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis.血管活性肠肽基因多态性与其血清水平相关,可预测早期类风湿关节炎的治疗需求。
Sci Rep. 2018 Feb 1;8(1):2035. doi: 10.1038/s41598-018-20400-6.